The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 48 | — | 20.1x | Near average | |
Growth | 62 | 25.6% | 5.6% | Near average | |
Quality | 93 | 102.2% | 7.6% | Above average | |
Safety | 41 | 1.1x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Arteris, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Arteris, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The analyst outlook for Arteris has experienced a contraction in coverage scope, as the number of analysts providing target prices decreased from two to only one over the past 30 days. Although the average target price remained stable at 36.5 dollars, this stability stems from a lack of new updates rather than shared optimism, increasing uncertainty regarding the fair value of the stock, which is currently trading at 36.01 dollars—very close to the target price.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.